Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-16 2:58 pm Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 99,714,985 14.22% | 10,100 (+0.01%) | View |
| 2024-02-21 2:00 pm Purchase | 13D | XPERI INC XPER | Rubric Capital Management LP | 4,043,744 9.3% | 307,525 (+8.23%) | View |
| 2024-02-14 10:28 am Purchase | 13D | XPERI INC XPER | Rubric Capital Management LP | 3,736,219 8.6% | 435,000 (+13.18%) | View |
| 2024-02-12 06:06 am Purchase | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Rubric Capital Management LP | 6,644,530 7.04% | 6,644,530 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | GOODRX HLDGS INC GDRX | Rubric Capital Management LP | 5,872,806 6.36% | 5,872,806 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | GOLAR LNG LTD GLNG | Rubric Capital Management LP | 6,506,757 6.21% | 154,001 (+2.42%) | View |
| 2024-02-12 06:06 am Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Rubric Capital Management LP | 2,907,501 8.21% | 2,907,501 (New Position) | View |
| 2024-02-12 06:06 am Sale | 13G | OVID THERAPEUTICS INC OVID | Rubric Capital Management LP | 5,315,969 7.52% | -1,512,096 (-22.15%) | View |
| 2024-02-12 06:06 am Sale | 13G | PAR PACIFIC HOLDINGS INC PARR | Rubric Capital Management LP | 1,199,749 1.98% | -1,849,251 (-60.65%) | View |
| 2024-02-12 06:06 am Purchase | 13G | SCPHARMACEUTICALS INC SCPH | Rubric Capital Management LP | 3,500,000 9.76% | 3,500,000 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | SUTRO BIOPHARMA INC STRO | Rubric Capital Management LP | 3,344,810 5.49% | 132,938 (+4.14%) | View |
| 2024-02-12 06:06 am Sale | 13G | DIGIMARC CORP DMRC | Rubric Capital Management LP | 0 0% | -1,214,593 (Position Closed) | View |
| 2024-02-12 06:06 am Purchase | 13G | SCHWEITZER-MAUDUIT INT'L INC SWM | Rubric Capital Management LP | 4,000,000 7.38% | 980,000 (+32.45%) | View |
| 2024-02-12 06:06 am Purchase | 13G | ANI PHARMACEUTICALS INC ANIP | Rubric Capital Management LP | 1,125,000 5.51% | 1,125,000 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | BGC GROUP INC BGC | Rubric Capital Management LP | 20,000,000 5.17% | 20,000,000 (New Position) | View |
| 2024-02-12 06:06 am Sale | 13G | CHIMERIX INC CMRX | Rubric Capital Management LP | 0 0% | -4,779,020 (Position Closed) | View |
| 2024-02-12 06:06 am Sale | 13G | COLLEGIUM PHARMACEUTICAL INC C COLL | Rubric Capital Management LP | 2,758,253 8.46% | -575,375 (-17.26%) | View |
| 2024-02-12 06:06 am Purchase | 13G | WEREWOLF THERAPEUTICS INC HOWL | Rubric Capital Management LP | 1,935,357 5.35% | 99,970 (+5.45%) | View |
| 2024-02-12 06:06 am Sale | 13G | KOPPERS HOLDINGS, INC. KOP | Rubric Capital Management LP | 1,007,341 4.84% | -126,499 (-11.16%) | View |
| 2024-02-12 06:06 am Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Rubric Capital Management LP | 0 0% | -8,294,621 (Position Closed) | View |